Abstract
Nicotine is an important component in cigarette smoke that can activate the growth-promoting pathways to facilitate the development of lung cancer. However, the intracellular mechanism(s) by which nicotine promotes survival of lung cancer cells remains enigmatic. Bad is a proapoptotic BH3-only member of the Bcl2 family and is expressed in both small cell lung cancer and non-small cell lung cancer cells. Here we report that nicotine potently induces Bad phosphorylation at Ser112, Ser136, and Ser155 in a mechanism involving activation of MAPKs ERK1/2, PI3K/AKT, and PKA in human lung cancer cells. Nicotine-induced multi-site phosphorylation of Bad results in sequestering Bad from mitochondria and subsequently interacting with 14-3-3 in the cytosol. Treatment of cells with PKC inhibitor (staurosporine), MEK-specific inhibitor (PD98059), PI3 kinase inhibitor (LY294002), or PKA inhibitor (H89) blocks the nicotine-induced Bad phosphorylation that is associated with enhanced apoptotic cell death. The fact that beta-adrenergic receptor inhibitor (propranolol) blocks nicotine-induced activation of ERK1/2, AKT, PKA, Bad phosphorylation, and cell survival suggests that nicotine-induced Bad phosphorylation may occur through the upstream beta-adrenergic receptors. The fact that specific knockdown of Bad expression by RNA interference using short interfering RNA enhances cell survival and that nicotine has no additional survival effect on these cells suggests that Bad may act as a required target of nicotine. Thus, nicotine-induced survival may occur in a mechanism through multi-site phosphorylation of Bad, which may lead to development of human lung cancer and/or chemoresistance.
Highlights
Lung cancer is one of the leading causes of cancer death, with a 5-year relative survival rate of 15% in both men and women worldwide [1,2]
We have recently discovered that nicotine induces Bcl2 phosphorylation at Ser70 through activation of mitogen-activated protein kinases (MAPKs), extracellular signal-regulated kinase (ERK)1/2, and protein kinase c (PKC)␣ that may contribute to nicotine-induced survival and chemoresistance of lung cancer cells [23]
We have recently demonstrated that nicotine induces Bcl-2 phosphorylation at Ser70 and potently promotes survival of human small cell lung cancer (SCLC) H69 cells [23]
Summary
Lung cancer is one of the leading causes of cancer death, with a 5-year relative survival rate of 15% in both men and women worldwide [1,2]. We report that nicotine potently induces Bad phosphorylation at Ser112, Ser136, and Ser155 in a mechanism involving activation of MAPKs ERK1/2, PI3K/AKT, and PKA in human lung cancer cells.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have